Mitsunaga Tada

Engages in research and development, manufacture, sales, export and import of pharmaceutical products

Functions as a College/University

RCP is a hands-on manager which strives to formulate and execute strategies that increase corporate value collaboratively, actively participating in the management of the investee company with shareholders, executives, and employees. The firm invests in proficient businesses which have high potential for growth in the Pan-Asian region, with Japan as the primary focus. They seek to accelerate business growth by identifying the investee company's latent areas of growth and implementing strategies to realize the company's true corporate value. RCP introduces new compensation schemes that reflect the performance of the company and their executives, which are evaluated based on the business strategies, management plan, and operational indexes that are agreed in advance. The firm also makes milestone investments, positioned as cumulative investments along with business buyouts and turnarounds, teaming with industrial partners to create substantial corporate value. Their typical investment targets include profitable subsidiaries and business divisions that have become subject to sellout due to business restructuring or strategy revision of the parent company; carve-out business divisions that are unable to fully utilize their technological expertise due to the inefficiencies of large organizations; medium-sized enterprises that are in need of operational fortification, such as business succession; turnaround bankrupt enterprises or those that require liquidation of past estates and other diversified investments and milestone investments in venture businesses that are in expanding markets like IT and bio-technology and possess a clear technological advantage. RCP seeks to make majority investments in order to gain control of the investee company, making joint investments with strategic investors if necessary. The firm considers the first three years the buildup period, and the following five years the exit period, and seeks to realize profit from their investment through IPOs or sellouts to strategic investors, with five years as the target time span.